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Abstract
Background: Mid-range inhomogeneity or MRI is the significant enrichment of particular nucleotides in genomic
sequences extending from 30 up to several thousands of nucleotides. The best-known manifestation of MRI is
CpG islands representing CG-rich regions. Recently it was demonstrated that MRI could be observed not only
for G+C content but also for all other nucleotide pairings (e.g. A+G and G+T) as well as for individual bases.
Various types of MRI regions are 4-20 times enriched in mammalian genomes compared to their occurrences in
random models.
Results: This paper explores how different types of mutations change MRI regions. Human, chimpanzee and
Macaca mulatta genomes were aligned to study the projected effects of substitutions and indels on human
sequence evolution within both MRI regions and control regions of average nucleotide composition. Over 18.8
million fixed point substitutions, 3.9 million SNPs, and indels spanning 6.9 Mb were procured and evaluated in
human. They include 1.8 Mb substitutions and 1.9 Mb indels within MRI regions. Ancestral and mutant (derived)
alleles for substitutions have been determined. Substitutions were grouped according to their fixation within
human populations: fixed substitutions (from the human-chimp-macaca alignment), major SNPs (> 80% mutant
allele frequency within humans), medium SNPs (20% - 80% mutant allele frequency), minor SNPs (3% - 20%), and
rare SNPs (<3%). Data on short (< 3 bp) and medium-length (3 - 50 bp) insertions and deletions within MRI
regions and appropriate control regions were analyzed for the effect of indels on the expansion or diminution of
such regions as well as on changing nucleotide composition.
Conclusion: MRI regions have comparable levels of de novo mutations to the control genomic sequences with
average base composition. De novo substitutions rapidly erode MRI regions, bringing their nucleotide
composition toward genome-average levels. However, those substitutions that favor the maintenance of MRI
properties have a higher chance to spread through the entire population. Indels have a clear tendency to maintain
MRI features yet they have a smaller impact than substitutions. All in all, the observed fixation bias for mutations
helps to preserve MRI regions during evolution.
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Background
The protein coding sequences of humans and of most
other mammals represent less than 2% of their genomes.
The remaining 98% is made up of 5'- and 3'-untranslated
regions of mRNAs (<2%), introns (~37%), and intergenic
regions (~60%) [1]. These vast non-protein coding
genomic areas, previously frequently referred to as "junk"
DNA, contain numerous functional signals of various ori-
gin and purpose. They include thousands of non-protein
coding RNAs [2], numerous gene expression regulatory
signals that surround each gene, chromatin folding struc-
tures which include nucleosome positioning sites and
scaffold/matrix attached regions [3,4]. These functional
DNA regions are non-random in their genomic sequence.
The non-randomness or inhomogeneity of base composi-
tion has been described at different levels of complexity
and sequence length. Starting on the short scale, inhomo-
geneity occurs in the non-random associations of neigh-
boring bases with each other [5], through the over and
under-abundance of particular "words" (usually 5-10 base
long oligonucleotides) [6] or longer stretches of DNA,
also known as "pyknons" (~18 bases long) [7,8], and up
to large regions that cover hundreds of thousands of
nucleotides [9]. Compositional inhomogeneity is known
to exist in all kinds of species from bacteria to human.
However, the particular arrangement of such sequence
patterns is often species-specific [10].
It has been the focus of our research to elucidate the
genomic sequence non-randomness that we call Mid-
Range Inhomogeneity or MRI [11]. We define MRI to be
genomic regions from 30 bp to several thousand nucle-
otides with particular nucleotide enrichments. For large
mammalian genomes, there is a high probability that a
random sequence of length 20 nucleotides will be unique.
Thus, for examining mid-range genomic signals we do not
look at particular "words" but only the overall composi-
tional content of particular base(s) that we refer to as X (X
could be a single nucleotide A, G, C, or T or any of their
combinations like A+C, or G+T+C). We created a public
Internet resource, "Genomic MRI" to study the distribu-
tion of X-rich regions in any sequence of interest. It was
demonstrated that X-rich MRI regions are highly overrep-
resented in mammalian genomes for all kinds X-contexts.
Particular properties of MRI have also been investigated
previously by Mrazek and Kypr [12] and also by Nikolaou
and Almirantis [13]. This paper studies the effect of muta-
tions on the evolution of MRI regions in primates.
Results
Substitution and polymorphism inside MRI regions
¿From the whole-genome human-chimp-macaque align-
ment we extracted all the aligned sequences with inhomo-
geneous nucleotide compositions that satisfy the criteria
for MRI (so-called X-rich MRI regions; see the Materials
and Methods section) and also control regions with nucle-
otide compositions equal to the average values for the
entire human genome. We used the default MRI region
length of 100 nucleotides for all computations. Only
SNPs located within these MRI and control regions were
studied. We particularly focused on the single nucleotide
substitutions that maintain or erode MRI features. For
example, in GT-rich MRI regions we counted the total
number of novel polymorphisms that erode the feature,
i.e. G or T → C or A substitutions, denoted as NGT→CA and
also the total number of those that maintain the MRI fea-
tures, i.e. C or A → G or T substitutions, denoted as
NCA→GT. In addition, the entire set of recent human substi-
tutions; that is, those nucleotides that differed in human
but were the same in chimp and macaque, were processed
for the MRI and control regions and presented as "fixed
substitutions". The substitution ratio, SX (recall that: SX =
NX→nonX/NnonX→X) for the numbers of substitutions that
maintain and erode X-rich MRI features was calculated for
each substitution subtype (rare, minor, medium, and
major SNPs and 'fixed'--refer to the Methods section for a
detailed explanation) and presented in Figures 1 and 2.
With respect to X-rich or poor MRI regions, the X in Figure
1 represents a two base combination such as GC, AG, GT,
etc. while in Figure 2X can be any single nucleotide, e.g.,
A, T, C, and G. If the SX-ratio is equal to 1 the X-rich region
does not tend towards a change in its X-base composition.
When SX > 1, the substitutions reduce the X-richness of the
examined regions, whereas when SX < 1, substitution rates
elevate the X-richness of the regions. Figures 1 and 2 dem-
onstrate clear linear trends for SX-ratios with respect to
increasing fixation of substitutions within human popula-
tions.
For the cases of GT-, AC-, AG-, and TC-rich MRI regions
(Figure 1), all S-ratios for rare SNPs are close to 1.8 (show-
ing erosion of the MRI features). For major SNPs and fixed
mutations the SGT and SAC-ratios reach 1.0 (which means
no change in the corresponding base composition) and
SGA and SCT-ratios reach 1.2 respectively. As for the corre-
sponding control GT-, AC-, AG-, and TC-average regions
(all having 50% of corresponding base composition)
these lines are flat with all S-ratios equal to 1. The latter
result is highly expected because of the symmetry of (+)
and (-) chromosomal strands for these particular base
compositions. Figure 1 also demonstrates that in GC-rich
MRI regions the SGC-ratio change has the highest slope
from 7.0 for rare SNPs to 1.6 for fixed substitutions. In AT-
rich MRI regions (also referred to as nonGC-rich in the
tables) the change of SAT-ratio has the lowest slope start-
ing from 1.7 (rare SNPs) and ending at 1.3 (fixed substi-
tutions). The control regions with the average GC/AT
compositions (40-42% GC and 58-60% AT) also demon-
strate a clear change of S-ratios during substitution fixa-
tion. In the control GC-average regions, rare SNPs favorBMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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increasing AT-richness (SGC-ratio of 1.3) whereas fixed
mutations demonstrate the opposite effect (SGC-ratio of
0.8).
The data for the S-ratios for single nucleotides (Figure 2)
are very similar to the trends seen in GC- and AT-rich
regions. As expected from (+/-) strand symmetry, SG-ratios
are equal to SC-ratios and represent about a half of the GC
trend. The minor differences between G- and C-rich
regions are within the errors of measurement. In the same
way the SA-ratios are seen to be the same as the ST-ratios
and they comprise approximately half of the effect seen
for AT-rich regions.
Substitution Rates in MRI Regions for a Combination of Nucleotides Figure 1
Substitution Rates in MRI Regions for a Combination of Nucleotides. For each X MRI region--where X is for GC-, 
GT-, or GA-rich or poor regions--the X-base composition rate of change is given for all substitutions at different levels of fixa-
tion within the human population. The rate of change (SX) is the ratio of X to nonX substitutions over nonX to X substitutions 
in those particular X-rich regions. Thus, a ratio of 1 means no change in the X-richness of the region whereas a ratio greater 
than 1 implies degradation of the X-rich region and less than 1 implies enrichment of the X-rich MRI region. Note that in the 
control X-average regions the SX-ratio is always inverse to SnonX-ratio (SX = 1/SnonX). Therefore, only one graph for each SX and 
SnonX pair is presented. Since there are significant variations in SX-ratios for different X compositions, the graphs are presented 
in two different scales. The white background presents changes of SX-ratios in the 0.8 to 2 range, while the gray background 
presents changes in the 0 to 7 range. Vertical bars show the standard error of the means (see Methods section).BMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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Substitution Rates in MRI Regions for Single Nucleotides Figure 2
Substitution Rates in MRI Regions for Single Nucleotides. For each X MRI region--where X is for A-, T-, G-, or C-rich 
or poor regions--the X-base composition rate of change is given for all substitutions at different levels of fixation within the 
human population. The rate of change (SX) is the ratio of X to nonX substitutions over nonX to X substitutions in those partic-
ular X-rich regions. Thus, a ratio of 1 means no change in the X-richness of the region whereas a ratio greater than 1 implies 
degradation of the X-rich region and less than 1 implies enrichment of the X-rich MRI region. Note that in the control X-aver-
age regions the SX-ratio is always inverse to SnonX-ratio (SX = 1/SnonX). Therefore, only one graph for each SX and SnonX pair is 
presented. Since there are significant variations in SX-ratios for different X compositions, the graphs are presented in two dif-
ferent scales. The white background presents changes of SX-ratios in the 0.8 to 2 range, while the gray background presents 
changes in the 0 to 7 range. Vertical bars show the standard error of the means (see Methods section)BMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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Based on the observed SX-ratios and the current percent-
age of X bases in the genomic regions under investigation,
we calculated the projected equilibrium composition rep-
resenting the future X-composition toward which the
examined substitution rates drive these regions. In other
words, the equilibrium X-composition shows the future
level of X-richness that would be approached if the SX-
ratio as it is observed now were maintained indefinitely.
The computed equilibria for each subgroup of substitu-
tions are presented in Table 1. For instance, in the GA-rich
regions (G+A composition of 70%), rare SNPs drive GA-
richness of these MRI regions down to an equilibrium of
56.6%, while nearly fixed or fixed substitutions drive the
GA-composition only to the 65.8% level. For each type of
X-rich MRI, there is a trend toward minimizing the dam-
age of mutations and preserving the MRI feature as the fix-
ation of the observed substitutions increases. The highest
preservation effect is seen for GT- and AC-rich regions
(with an observed X-base composition of 70%), where the
equilibria for fixed substitutions reach about the same
level of 70%. For the rest of the types of MRI regions, their
equilibria composition is a little below the currently
observed base composition.
In order to estimate mutation rates for MRI regions versus
their respective control regions, we counted the occur-
rence rates for rare SNPs. The frequency ratio of rare SNPs
in MRI rich regions to those in the control regions was cal-
culated. The smallest ratio observed was for A+C content
(0.464). This means the frequency of rare SNPs within
MRI AC-rich regions is approximately half that of control
regions. The highest occurrence ratio for rare SNPs was
observed in G- and C-rich MRI regions (1.16 and 1.17
respecitvely). Thus, the occurrence rates of rare SNPs is
slightly lower in MRI regions than in the corresponding
control regions with the exception of G- and C-rich MRI
regions. The entire dataset for the SNPs occurrences in
MRI and control regions is presented in Additional file 1.
The prevalence of rare and minor SNPs over major SNPs
was also observed, their proportion over every MRI and
control regions being 5.79.
Table 1: Projected X-Equilibria. 
Equilibrium for X-percentage computed from each substitution rate
Type of region Observed X-percentage rare SNPs minor SNPs Medium SNPs major SNPs fixed substit.
G-rich 40% 14.5% 16.9% 22.3% 36.0% 32.1%
nonG-rich 7% 14.6 13.4 10.6 7.6 7.8
G-average 20% 17.1 18.0 19.2 23.0 22.2
C-rich 40% 13.8 16.9 23.0 33.90 32.4
nonC-rich 7% 14.5 12.7 10.2 8.0 7.8
C-average 20% 17.1 18.1 19.2 23.1 22.1
A-rich 49.5% 41.4 40.3 42.0 43.5 44.1
nonA-rich 12.9% 32.3 26.3 20.8 10.9 12.6
A-average 29.4% 34.1 32.6 30.7 26.0 27.0
T-rich 49.5% 39.5 39.5 42.8 43.2 44.6
nonT-rich 12.9% 33.4 27.3 19.9 11.5 12.6
T-average 29.4% 34.2 32.6 30.8 25.9 27.1
GT-rich 69.8% 56.9 60.7 64.6 70.8 70.4
nonGT-rich 30.1% 41.7 37.7 36.5 29.2 30.1
GT-average 50.0% 49.9 50.0 50.0 50.0 50.0
GA-rich 70.0% 56.6 56.6 60.0 63.2 65.8
nonGA-rich 29.9% 44.6 42.1 39.1 31.7 34.1
GA-average 50.0% 49.9 50.1 50.0 49.9 49.9
GC-rich 71.3% 26.4 31.7 39.5 56.1 60.6
nonGC-rich 20.0% 30.2 29.3 27.8 27.4 24.4
GC-average 40.7% 34.9 36.8 39.0 45.7 45.0
The calculated equilibria percentages (see Equation 3) for X-bases in X-rich MRI and control regions with average X-composition. Projected 
equilibria are given based on the substitution rates of rare, minor, medium, and major SNPs as well as for the fixed substitution rates (chimp-
macaque to human).BMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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Insertions and deletions inside MRI regions
Using the same computational approach as for substitu-
tions, we analyzed human-chimp-macaque triple align-
ments for the characterization of indels  (insertions &
deletions) that occurred in the human genome during the
last 10 million years after the divergence of H. sapiens and
P. troglodytes species. We particularly investigated how
indels change the nucleotide composition of MRI regions
and control regions with average nucleotide composition.
The complete set of data representing short indels (whose
sizes are less than three nucleotides) and medium indels
(whose sizes are from three to fifty nucleotides) is pre-
sented in Additional file 2 (S2A--contains MRI for combi-
nations of nts; S2B--MRI for individual nts). Large indels
with sizes over 50 bp were not examined since they are
comparable with the sizes of MRI regions and, thus, com-
promise proper characterization of MRI. The summary
data on the influence of both short and medium indels on
the composition of MRI and control regions are presented
in the Tables 2 and 3 (Table 2 shows MRI regions where X
represents any single nucleotide; Table 3 is for when X
represents any combination of 2 nucleotides). For each
type of X-rich and X-control regions the total number of
inserted and deleted X and nonX nucleotides have been
computed: Nins(X), Nins(nonX), Ndel(X), Ndel(nonX). Finally, the
net change in X and nonX compositions due to indels have
been calculated using the following formulas:
Tables 2 and 3 demonstrate that in the human genome
there is a prevalence of deletions over insertions (i.e. neg-
ative values of ΔX and ΔnonX) for every type of nucleotide
content studied and for every type of MRI and control
region with the exception of GC-indels in GC-rich MRI
regions. In the last case ΔGC is positive and equal to 1405
added nucleotides (over a total set of 1.8 million nucle-
otides). For all other cases of X except X = GC, short and
medium indels cause gradual contraction of genomic
regions in humans. This means that there is no nucleotide
composition equilibrium to which the indels drive the
genome in the indefinite future and, therefore, these equi-
libria have not been calculated. Table 2 shows that, for
every X-rich region, indels result in the increasing the rich-
ness of corresponding MRI regions (positive net X%
change for X-rich region and negative net X% change for
nonX-rich region). In all X-control regions the net X%
change is several times less than in the corresponding X-
rich and nonX-rich regions.
Finally, we calculated the percentage of nucleotide com-
position changes in case of both substitutions and indels
separately, that occurred in the human genome during
last ten million years after the divergence of human and
chimpanzee. These results are presented in Tables 2 and 3
and serve to measure the relative importance of substitu-
tions versus indels to the nucleotide composition of MRI
regions.
Discussion
Consistent with Chargaff's second parity rule [14], both
the G or C base content of the human genome are equal
to 21.1%, while A or T comprise 28.9% each. However, in
thousands and thousands of genomic regions of various
lengths, the composition of A, T, C, or G content (or dif-
ferent combinations of these bases) exist at extremes quite
different from the aforementioned averages. De novo
ΔXN N ins X del X =− () ()
ΔnonX N N ins nonX del nonX =− () ()
Table 2: Impact of Indels on X-rich MRI Regions, with X 
Representing Any Single Base. The impact of indels on X-rich 
MRI regions and on X-average regions, where X is for A-, T-, C-, 
or G-rich or poor. For each particular region we give the total 
length of examined regions in mega-bases, the percentage 
composition or content of X, the number of changes in X due to 
insertions and deletions (ΔX = Nins(X) - Ndel(X)), and the change in 
X composition due to both indels and substitutions.
A-rich nonA-rich A-average
total length 66.9 Mb 72.4 Mb 800.4 Mb
content of A 49.6% 12.9% 30.5%
ΔA -16850 -7390 -44182
ΔnonA -24748 -29257 -98769
net A% change INDEL 0.006% -0.004% -0.0001%
net A% change SUBST -0.027% -0.002% -0.014%
T-rich nonT-rich T-average
total length 67.8 Mb 71.1 Mb 800.4 Mb
content of T 49.5% 13.1% 30.5%
ΔT -21849 -7078 -47238
ΔnonT -24084 -22716 -97057
net T% change INDEL 0.001% -0.004% -0.0004%
net T% change SUBST -0.024% -0.002% -0.013%
G-rich nonG-rich G-average
total length 52.0 Mb 60.4 Mb 884.7 Mb
content of G 40.10% 7.20% 20.40%
ΔG -1185 -7080 -31780
ΔnonG -12864 -37512 -139126
net G% change INDEL 0.009% -0.006% 0.0003%
net G% change SUBST -0.052% 0.009% 0.016%
C-rich nonC-rich C-average
total length 52.0 Mb 60.4 Mb 883.9 Mb
content of C 40.10% 7.20% 20.50%
ΔC -829 -6700 -33823
ΔnonC -12418 -35277 -140331
net C% change INDEL 0.009% -0.006% 0.0002%
net C% change SUBST -0.049% 0.009% 0.015%BMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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mutations constantly occur in populations and could dra-
matically change the base composition of a genomic
region during the course of evolution. A good choice for a
large-scale computational analysis of these novel muta-
tions is in the examination of 'rare' single-nucleotide pol-
ymorphisms (SNPs, or mutations that are present only in
a small group of individuals and absent in a majority of
the population). Rare SNPs are mutations that have
recently occurred. However, even among rare SNPs there
exists a minor subgroup of "older" mutations that have
diminished their frequency to rare events. The relative size
of this subgroup is in reverse proportion to the effective
size of the population [15], and hence, it represents only
a minor fraction of the recent mutations for humans. Here
we show that rare SNPs in genomic regions with average
nucleotide composition are enriched by G or C → T or A
substitutions that drive the genomic composition of those
regions to a level of 35% for G+C and 65% for A+T. On
the other hand, examining the same regions for mutations
that have substantially propagated into human popula-
tions (i.e. medium and high frequency SNPs as well as
"fixed" recent mutations) demonstrates that these fixed or
nearly fixed substitutions are much less prone to G or C →
T or A changes. Instead, high frequency SNPs as well as
fixed substitutions tend to drive genomic regions with
average base composition to 45% G+C composition.
Here we have focused particularly on the influence of
mutations on the evolution of specific genomic regions
with strongly inhomogeneous base compositions that are
far from the average distribution of nucleotides (so-called
MRI regions where G+C, G+A, C+T, G+T, or A+C compo-
sition is at least 70%, A+T composition is above 80%, or
single base frequency reaches nearly 50%). For all types of
MRI regions, we found that novel substitutions (rare
SNPs) tend to more strongly erode the compositional
extremes (X-richness) of the region. At the same time,
these mutations undergo a strong fixation bias during
their propagation into populations in such a way that
fixed substitutions tend to preserve MRI regions. For
example, rare SNPs inside GC-rich MRI regions drive the
nucleotide composition of those regions to the 26% GC
level. However, fixed substitutions in the same GC-rich
MRI regions drive GC composition only to 61%. The
highest fixation was seen for GT- and AC-rich MRI regions,
which preserves the current GT- and AC-composition of
70%.
This trend of preserving nucleotide composition of MRI
regions with respect to the increasing fixation of substitu-
tions could be explained by at least two different mecha-
nisms. First, one could observe that there are some
important functional roles for MRI regions. For instance,
GC-rich MRI regions include well-known CG-islands,
prominent regulators for gene expression [16,17]. Thus,
these regions should be under the constraint of purifying
selection, preserving their important features. Other MRI
regions may be under similar selective pressure due to
association with functional genomic elements and/or, as
yet unknown, sequence signals. Second, fixation bias
inside MRI regions might be due to some non-symmetry
in cellular molecular machinery involving DNA repair,
replication, and/or recombination processes. For exam-
ple, the Biased Gene Conversion (BGC)-theory engages
this particular scenario in order to explain the mainte-
nance of CG-rich regions [18,19]. (It must be observed,
however, that this theory operates on much larger
genomic scales and refers to isochores that cover from
hundreds of thousands to millions of bases.) Thus far it is
inconclusive as to which of these two scenarios, or a com-
bination thereof, best fits the observed trends. For the case
of GC-rich sequences, we conjecture that both scenarios
could be taking place to some extent to preserve MRI.
Interestingly, the highest level of MRI erosion for rare
SNPs is observed in GC-rich MRI regions. Novel substitu-
tions in these particular regions try to drive GC-content to
Table 3: Impact of Indels on MRI Regions, with X Representing 
Combinations of Any Two Bases. 
GC-rich nonGC-rich GC-average
total length 17.8 Mb 54.8 Mb 780.6 Mb
content of GC 71.00% 20.30% 40.90%
ΔGC 1405 -9100 -31622
ΔnonGC -765 -5951 -56278
net GC% change INDEL 0.005% -0.011% 0.001%
net GC% change SUBST -0.094% 0.042% 0.034%
GT-rich nonGT-rich GT-average
total length 34.9 Mb 34.6 Mb 1192 Mb
content of GT 69.10% 30.90% 50.00%
ΔGT -8278 -6837 -121644
ΔnonGT -4518 -8502 -120128
net GT% change INDEL 0.002% -0.006% -0.0001%
net GT% change SUBST 0.004% 0.001% -0.0003%
GA-rich nonGA-rich GA-average
total length 69.2 Mb 70.0 Mb 978.3 Mb
content of GA 69.75% 30.22% 49.99%
ΔGA -23641 -13935 -96617
ΔnonGA -14185 -28480 -100013
net GA% change INDEL 0.004% -0.002% 0.0002%
net GA% change SUBST -0.014% 0.014% 0.0002%
The impact of indels on X-rich MRI regions and on X-average regions, 
where X is for GC-, GT-, or GA-rich or poor. For each particular 
region we give the total length of examined regions in mega-bases, the 
percentage composition or content of X, the number of changes in X 
due to insertions and deletions (ΔX = Nins(X) - Ndel(X)), and the net 
change in X composition due to both indels and substitutions.BMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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the lowest level of 26% (see Table 1). We explain this phe-
nomenon via uneven distribution of CpG dinucleotides,
which are most abundant in GC-rich MRI regions. It is
well known that CpG dinucleotides are extreme hot spots
for the C → T and G → A mutations, which cause CpG to
be the most underrepresented dinucleotide in vertebrate
genomes. Therefore, CG-rich MRI regions, which are
known to have the highest concentration of CpG dinucle-
otides, should have the highest rate of de novo mutations
in the direction C or G → T or A. Human SNPs having C/
T alleles in the CpG/TpG context with the orthologous
chimp allele in the TpG context have an increased error
rate of 9.8% for ancestral misidentification (see the Meth-
ods section) due to the probability of a coinciding chimp
SNP at the same locus [20]. However, since the strength of
the mutational erosion in the GC-rich MRI regions is so
high, even an error rate of 9.8% will not change the
observed trend.
So far we have discussed only the effect of substitutions on
the nucleotide composition of mid-range genomic
regions. Insertions and deletions are the other types of
mutations that change genomic sequences and, therefore,
should also be considered. In mammals, short and
medium indels are several times less frequent than substi-
tutions. Currently, there is not enough data on human
indel SNPs to perform the same analysis of their fixation
process as we did for substitutions. For this reason we
studied only fixed indels in humans (indels present in
human but differing in chimp and macaque). Our exami-
nation demonstrated that indels weakly influence the
nucleotide content of MRI regions toward preserving their
inhomogeneous composition, in the same manner as the
fixation bias of fixed substitutions (see Tables 2 and 3).
Conclusion
The fixation bias on both fixed substitutions and indels
tend to protect MRI regions from degradation of their
compositional extremes amid the constant flow of ran-
dom mutations, thus suggesting their contribution in the
preservation of functional and structural complexities of
the human genome. Future research on these genomic ele-
ments as well as refinement of our approach should help
determine the extent of maintenance of MRI by natural
selection.
Methods
Genomic samples and computation of recent human 
mutations ("fixed substitutions")
Taking human-chimp (human build 36.1 and chimp
build 2 version 1) and human-macaque (macaque build
v1 edit4) whole-genome pairwise alignments from the
UCSC Genome Browser [21]http://hgdown
load.cse.ucsc.edu/downloads.html as input, we generated
a Perl script for the identification of the common genomic
regions for these three species. The process involved the
usage of the human genomic sequence as the reference for
the location with the chimp and macaque sequences
being extracted only in areas where the sequences of all
three species were represented. We then invoked the Clus-
talW (v1.83) program with default parameters to obtain a
whole-genome human-chimpanzee-macaque triple align-
ment. The obtained alignment is available at our website
http://bpg.utoledo.edu/human_chimp_macaque.html.
This triple alignment was used to calculate the dataset of
recent mutations in humans. We considered a recent sub-
stitution at a particular position (for example T → C at
position 23456719 on chromosome 7) to be valid if the
human genome has a C base while both chimp and
macaque have a T base in the corresponding aligned posi-
tions. In addition, we required that the quality of the
alignment in the vicinity of the mutation be reliable
(more than 70% similarity between human and macaque
in the 20 bp flanking region [-10, +10]). The frequency
table of all inferred recent human mutations is presented
in the Additional file 3. We analyzed these recent substi-
tutions together with the SNP datasets and call the former
mutations "fixed substitutions," assuming that the major-
ity of them occurred less than 10 million years ago and
were already fixed across all human populations. In the
same manner we processed indels in the triple alignments
and computed all unambiguous cases of human inser-
tions and deletions with sizes from 1 to 49 nucleotides.
Processing of SNP data
Over 4.62 million human SNPs from all chromosomes
were obtained (dbSNP build 128 [22], ftp://
ftp.ncbi.nih.gov/snp/), filtered for completeness and cor-
rectness annotations (676499 records discarded total),
and mapped onto the whole-genome human-chimpanzee
alignment. SNP allele frequencies were averaged from the
frequency data of all populations of that allele. However,
only those SNPs that were successfully located within the
alignment were processed further. For each SNP site we
verified the existence of the particular polymorphic bases
in the specified position of the human genome reference
sequence and also in the corresponding aligned position
on the chimp genomic sequence. If any of these two spe-
cies had different bases than the SNP alleles, the SNP was
discarded (20469 SNPs discarded total).
Otherwise, we defined the origin of the polymorphism
based on the chimpanzee nucleotide. Consider the fol-
lowing example to illustrate this process: suppose one has
an A/G polymorphism located at position 34567812 of
chromosome 5 with an average A allele frequency of 0.6
and a G allele frequency of 0.4. Then at position
34567812 of chromosome 5 of the human genome refer-
ence sequence (Genbank build 36.1), we would first
examine if the A or G allele is present at that position andBMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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discard the SNP if not. Next, using the flanking region of
that SNP we could align the chimp genomic sequence. If
the chimp nucleotide were T or C then the SNP would also
be discarded because those alleles are not a part of the
human haplotype at that position. However supposing
that the chimp nucleotide were G, then the polymor-
phism would be declared as a G → A polymorphism with
G being declared the ancestral allele that at some point in
human evolution mutated into an A allele within some
human population(s). From the frequency data we may
finally characterize this example SNP more precisely as a
0.4G → 0.6A polymorphism.
Using this approach we successfully characterized 3.93
million human SNPs. This last group of SNPs was divided
into four subgroups based on the abundance of the
mutant allele in the given human populations:
I. rare polymorphisms with the frequency of the mutated
allele being less than 3%;
II. minor polymorphisms with frequencies ranging from 3%
to 20%;
III. medium polymorphisms with frequencies going from
20% to 80%; and
IV. major polymorphisms with the frequency being above
80%.
For our method, misidentification of the ancestral allele
might arise when the site for the human SNP is also poly-
morphic in chimp populations (e.g. A/G polymorphism)
or for the possible case that this site had a recent substitu-
tion in chimps (A → G) after their divergence from
humans. Human and chimpanzee genomes only differ by
1.23% due to single nucleotide substitutions with 1.06%
being due to fixed substitutions and the rest (0.17%)
being due to polymorphisms in human and chimp [20].
Moreover, according to the Chimpanzee Sequencing and
Analysis Consortium the average estimated error rate of
human alleles being misidentified due to chimp polymor-
phisms is only ~1.6% across all typical SNPs, which is
acceptably low. It is also observed, however, that in the
mutational hotspot of the CpG dinucleotide, there is an
increased error rate for ancestral misidentification. If the
human alleles are C/T in the CpG and TpG context and
the chimp allele is T (in the TpG context) then the esti-
mated error rate is actually 9.8% [20]. Thus, in the context
of studying our MRI regions, any substitution (especially
in GC-rich MRI regions since they contain an overabun-
dance of G and C) going from TpG → CpG could have the
ancestral allele misidentified, which would mean that the
substitution would actually be CpG → TpG, although in
the case of GC-rich MRI regions where such dinucleotides
are more likely, an error rate of 9.8% is not sufficient to
change the trend or conclusion of our results.
X-rich MRI genomic regions and control regions with 
average base composition
Any base or combination of bases can be described by a
parameter X. For example, X could be G-base; C+T-bases;
or A+T+G bases, et cetera. It is also useful to refer to nonX
base(s) as all bases not X. Thus, X + nonX must represent
all four nucleotides A, G, T, and C. For the examples
above,  nonX  are A+T+C-bases; G+A-bases, and C-base,
respectively. MRI is characterized by a specific base com-
position within a region under analysis. We characterize
X-rich MRI regions based on an overabundance of the X
base(s) within a region of a certain length (the so-called
window), where the percentage of X should be above a
certain threshold (Bechtel et al 2008). We calculated MRI
regions in the human genome for single nucleotides and
various nucleotide combinations using a stretchy window
of 100+ nucleotides with the following threshold param-
eters: for A or T the threshold was 49%; for G or C we used
40%; for G+C it was 70%; for A+T the threshold was at
80%; for G+T, C+A, G+A, and C+T were at 70%; nonA or
nonT was 87%; and non G or non C the threshold was
93%. These thresholds were chosen experimentally in
such a way that MRI regions should represent about 2% of
the whole human genome. A stretchy window of N  +
nucleotides means that we scan genomic sequence with
an N-size window to find a genomic MRI region that fits
the threshold criterion, then we extend the window above
the detected region by 10 nt steps until the criterion is no
longer met. After registering the full MRI region we jump
beyond the current MRI region and continue with the
default N-size window. Using this approach we character-
ized all MRI regions in the triple human-chimp-macaque
alignments using the human sequence for calculating
nucleotide composition and MRI features. We also dis-
carded those MRI regions in the alignments where the
indel composition exceeded 50%. For the collection of
control regions with average base compositions we used
the same stretchy window approach with the nucleotide
composition corresponding to the following average
genomic frequencies: for A, T between 30 and 31% thresh-
olds; for G, C between 20-21%; for G+C between 40-42%;
A+T at 58-60%; G+T, C+A, G+A, or C+T were at 49-51%.
Note that control regions with genome-average X-compo-
sition also have genome-averaged nonX-composition.
Therefore, their subsitution ratios are in inverse propor-
tion to each other: SX = 1/SnonX. Due to this only one ratio
for X and nonX pair is shown in Figures 1 and 2.BMC Genomics 2009, 10:513 http://www.biomedcentral.com/1471-2164/10/513
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Calculation of the substitution ratios in MRI and control 
regions
Studying SNPs and fixed substitutions in X-rich MRI
regions we measured the number of changes from X to
nonX  (denoted as NX→nonX) and also the number of
changes from nonX to X (denoted as NnonX→X). The fluctu-
ations in the observed distribution of NX→nonX and NnonX→X
are well-known as Poisson noise. Thus, the standard devi-
ation for the true values for NX→nonX and NnonX→X is calcu-
lated according to v the Poisson distribution, that is: σN =
. For each X-rich MRI region we measured the substi-
tution SX-ratios with SX = NX→nonX/NnonX→X shown in Fig-
ures 1 and 2. The propagation of uncertainty for a ratio f
= A/B can be calculated using the formula (σf/f)2 = (σA/A)2
+ (σB/B)2 - 2(σA·σB)/(A·B)·ρAB, where ρAB is the correla-
tion coefficient for A  and  B  variables. Because the
observed frequency of having a SNP at a genomic site in
humans is less than 1%, it is correct to assume that the
correlation between NX→nonX and  NnonX→X is negligible.
Therefore, the standard deviation for the SX ratio was cal-
culated by the following formula:
Calculation of base composition equilibrium for the 
observed substitution rates
As described in the previous paragraphs, for studying
SNPs and fixed substitutions in X-rich MRI regions of the
human genome we measured the number of changes
from X to nonX (denoted as NX→nonX) and also the number
of changes from nonX to X (denoted as NnonX→X). These
NX→nonX and NnonX→X helped us to estimate the frequencies
of these two types of mutations per X or nonX site, named
here as FX→nonX and  FnonX→X, correspondingly. Suppose
one has a sample of MRI regions with a total nucleotide
sequence length of L and a composition of X with the
region richness given as PX being measured in numbers
from 0 to 1. Then, the total number of X sites in this sam-
ple will be L·PX, and the total number of nonX sites will
be L·(1 - PX). During a certain time interval called ΔT
there will be ΔNX→nonX and ΔNnonX→X substitutions. There-
fore the frequency of substitutions per site is FX→nonX =
ΔNX→nonX/(ΔT·L·PX) and FnonX→X = ΔNnonX→X/(ΔT·L·(1 -
PX)). It is impossible to measure directly these ΔN values
for a specific time interval of ΔT. However, with a good
approximation we can assume that the frequencies are
proportional to the observed numbers NX→nonX  and
NnonX→X and can be represented by the simple formula:
FX→nonX = A·NX→nonX/PX and FnonX→X = A·NnonX→X/(1 - PX),
where  A  is a scaling factor having the same value for
FX→nonX  and  FnonX→X, since NX→nonX  and  NnonX→X  are
counted from the same sample. In a gedanken experi-
ment, let's assume that the current FX→nonX and FnonX→X val-
ues will stay unchangeable forever for our MRI sample.
Then, in time, mutations should alter the base composi-
tion of our sample until it reaches an equilibrium compo-
sition with a new percentage for X-bases denoted here as
QX. This equilibrium composition QX can be computed
using the observed parameters of PX,  NX→nonX, and
NnonX→X. Indeed, under the equilibrium, the number of
changes from X to nonX must be equal to the number of
reverse changes from nonX to X, or:
We can compute these ΔNX→nonX  and  ΔNnonX→X  values
from frequencies in such a way:
also in a similar way
By putting these transformations into Equation 1 we get:
or
Finally, simple transformation of Equation 2 gives us the
final Equation 3 for calculation of equilibrium percent-
age:
In the Results section, Formula 3 is used to compute the
equilibrium percentage for X-bases in the studied MRI
regions.
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rences of major, middle, minor and rare SNPs in all X MRI regions 
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etc.] or a single base) and their corresponding control regions, which have 
an average nucleotide composition for the respective X.
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Additional file 2
S2A - Indel data for combination of nts, S2B - Indel data for individ-
ual nts. ￿ 2A - Complete set of data representing the total number of X 
nucleotides (where X represents a two base combination such as GC, AG, 
GT, etc.) inserted or deleted due to short indels, whose sizes are less than 
three nucleotides in length, or medium indels, whose sizes range from 
three to fifty nucleotides in length, for all X MRI regions, and for the con-
trol regions, which have an average nucleotide composition for the respec-
tive X. ￿ 2B - Complete set of data representing the total number of X 
nucleotides (where X represents a single base) inserted or deleted due to 
short indels, whose sizes are less than three nucleotides in length, or 
medium indels, whose sizes range from three to fifty nucleotides in length, 
for all X MRI regions, and for the control regions, which have an average 
nucleotide composition for the respective X.
Click here for file
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2164-10-513-S2.xls]
Additional file 3
S3 - Dataset of fixed substitutions. Complete set of data representing the 
number of occurrences of fixed substitutions on all X MRI regions (where 
X could represent either a two-base combination [GC, AG, GT, etc.] or a 
single base), and the control regions, which have an average nucleotide 
composition for the respective X.
Click here for file
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